
- |
- Partner

Support multinational companies with actionable insights and growth strategies to achieve top line growth objectives across Asia.
Nicolas is a Partner based in our Shanghai office. He has advised Fortune 500 clients on strategic business issues for 18 years. Prior to Solidiance, Nicolas was a Senior Vice President and Head of Asia for an international industry research and advisory firm. He has advised clients on growth strategies, market opportunity analysis, competitive intelligence, M&A target evaluation & selection, and commercial due diligence in markets throughout Asia. He has lived and worked in the USA, Canada, the UK, Hong Kong and Shanghai..
- Education :
MBA – University of Chicago Booth School of Business , BCom in Finance and International , Business – McGill University , BA in Economics – University of London - Functional Experience :
Competition Benchmarking , Competitive Strategy , Due Diligence , Growth Strategy , Market Entry , Merger & Acquisition - Industry experience :
Chemical , Construction , Healthcare , Machinery , TMT (Telecommuncation, Media, Technology) - Relevant country experience :
China , Hong Kong , Mongolia , Japan , Korea , Taiwan
Publications
- Others
- -
- News
China as a solid supporter of the Paris Agreement
January 2019As COP24 in Katowice, Poland has finalized the implementation guidelines for the agreement, China has been a solid supporter of the accord’s principles. According to Nicolas Pechet, our...
- Others
- -
- News
Looking for China's leadership in climate conference
December 2018Our Shanghai-based partner, Nicholas Pechet, addressed China's industrial sector which starts to implement the government's 13th five-year plan. The plan includes the reduction of energy...
- Healing
- -
- Articles
Opportunities for medical device companies in China’s reforming healthcare industry
January 2018With China experiencing major trends like slow economic growth, a rapidly aging population, and greater incidence of costly non-communicable diseases, the government has begun a series of reforms...
- Healing
- -
- Articles
Discovering opportunities in China’s cardiovascular market
November 2017China has one of the world’s most complicated and regulated healthcare industries. It still takes at least two years for most drugs and medical devices to obtain the necessary licenses to be sold...